MapLight Therapeutics Inc. (MPLT)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$18.38
Day's range
$20

MPLT Income statement / Annual

Last year (2025), MapLight Therapeutics Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2025, MapLight Therapeutics Inc.'s net income was -$161.15 M. See MapLight Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2025 FY-2024 FY-2023 FY-2022
Period Ended 12/31/2025 12/31/2024 12/31/2023 12/31/2022
Operating Revenue $0.00 $0.00 $0.00 $0.00
Cost of Revenue $578.00 K $701.00 K $556.00 K $574.00 K
Gross Profit -$578.00 K -$701.00 K -$556.00 K -$574.00 K
Gross Profit Ratio 0 0 0 0
Research and Development Expenses $137.77 M $67.82 M $49.12 M $26.57 M
General & Administrative Expenses $0.00 $14.42 M $7.61 M $4.10 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $30.73 M $14.42 M $7.61 M $4.10 M
Other Expenses $0.00 $0.00 $0.00 $0.00
Operating Expenses $168.51 M $82.25 M $56.73 M $30.67 M
Cost And Expenses $169.08 M $82.95 M $57.28 M $31.25 M
Interest Income $5.52 M $4.50 M $1.10 M $429.00 K
Interest Expense $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $578.00 K $701.00 K $556.00 K $574.00 K
EBITDA -$160.57 M -$76.88 M -$55.15 M -$29.44 M
EBITDA Ratio 0 0 0 0
Operating Income Ratio 0 0 0 0
Total Other Income/Expenses Net $7.93 M $5.37 M $1.57 M $1.23 M
Income Before Tax -$161.15 M -$77.58 M -$55.71 M -$30.02 M
Income Before Tax Ratio 0 0 0 0
Income Tax Expense $0.00 $0.00 $0.00 $0.00
Net Income -$161.15 M -$77.58 M -$55.71 M -$30.02 M
Net Income Ratio 0 0 0 0
EPS -3.66 -1.87 -1.34 -0.72
EPS Diluted -3.66 -1.87 -1.34 -0.72
Weighted Average Shares Out $44.02 M $41.43 M $41.43 M $41.43 M
Weighted Average Shares Out Diluted $44.02 M $41.43 M $41.43 M $41.43 M
Link